ESAB Corporation Announces Third Quarter 2026 Results
ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. ESAB Corporation Announces Third Quarter 2026 Results • Record total sales; increased 13.3%, with core organic sales up 2.3% • Core organic growth in both segments • EBXai driving margin expansion • Updating 2026 outlook North Bethesda, MD, November 4, 2026 -- ESAB Corporation (“
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The earnings beat on sales and margin is offset by a downward revision to EBITDA and EPS guidance, creating mixed signals for investors.
Market read
The release is a primary corporate disclosure with material financial updates that can move ESAB's stock and influence peers in the industrial sector.
What to watch
The company highlighted a 13.3% sales increase and margin expansion, which may support longer‑term upside despite short‑term guidance cuts.
ESAB reported record third quarter sales of $825 million, up 13.3% reported and 2.3% on a core organic basis, while updating its 2026 outlook.
Record sales, organic growth in both segments and a 40-basis-point expansion in core adjusted EBITDA margin were offset by lower GAAP operating income, net income and diluted EPS, as well as reductions to the full-year core adjusted EBITDA and core adjusted EPS outlook ranges.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net sales, three months ended October 2, 2026GAAP | $824.5M | – | 13.3% |
| Core net sales, three months ended October 2, 2026non-GAAP | $786.8M | – | 14.5% |
| Core organic sales growth, three months ended October 2, 2026non-GAAP | 2.3% | – | 2.3% |
| Gross profit, three months ended October 2, 2026GAAP | $323,643 | – | – |
| Gross profit margin, three months ended October 2, 2026GAAP | 39.3% | – | – |
| Adjusted gross profit, three months ended October 2, 2026non-GAAP | $326.2M | – | – |
| Adjusted gross profit margin, three months ended October 2, 2026non-GAAP | 39.6% | – | – |
| Adjusted core gross profit, three months ended October 2, 2026non-GAAP | $316.3M | – | – |
| Adjusted core gross profit margin, three months ended October 2, 2026non-GAAP | 40.2% | – | – |
| Selling, general and administrative expense, three months ended October 2, 2026GAAP | $220,382 | – | – |
| Restructuring and other related charges, three months ended October 2, 2026GAAP | $11,329 | – | – |
| Operating income, three months ended October 2, 2026GAAP | $91,932 | – | – |
| Net income from continuing operations, three months ended October 2, 2026GAAP | $42,160 | – | – |
| Net income, three months ended October 2, 2026GAAP | $40,275 | – | – |
| Net income attributable to ESAB Corporation, three months ended October 2, 2026GAAP | $38,922 | – | – |
| Net income attributable to common stockholders, three months ended October 2, 2026GAAP | $36,079 | – | – |
| Diluted earnings per share from continuing operations, three months ended October 2, 2026GAAP | $0.61 | – | – |
| Net income per share diluted, three months ended October 2, 2026GAAP | $0.58 | – | – |
| Adjusted net income from continuing operations, three months ended October 2, 2026non-GAAP | $84.5M | – | – |
| Core adjusted net income from continuing operations, three months ended October 2, 2026non-GAAP | $83M | – | – |
| Adjusted net income per share diluted from continuing operations, three months ended October 2, 2026non-GAAP | 1.32 | – | – |
| Core adjusted net income per share diluted from continuing operations, three months ended October 2, 2026non-GAAP | $1.30 | – | – |
| Adjusted EBITDA, three months ended October 2, 2026non-GAAP | $159M | – | – |
| Core adjusted EBITDA, three months ended October 2, 2026non-GAAP | $156.1M | – | 17.0% |
| Core adjusted EBITDA margin, three months ended October 2, 2026non-GAAP | 19.8% | – | 40 basis points |
| Net sales, nine months ended October 2, 2026GAAP | $2,377,745 | – | 12.1% |
| Gross profit, nine months ended October 2, 2026GAAP | $905,966 | – | – |
| Operating income, nine months ended October 2, 2026GAAP | $261,136 | – | – |
| Net income from continuing operations, nine months ended October 2, 2026GAAP | $130,352 | – | – |
| Net income, nine months ended October 2, 2026GAAP | $123,500 | – | – |
| Diluted earnings per share from continuing operations, nine months ended October 2, 2026GAAP | $1.96 | – | – |
| Net income per share diluted, nine months ended October 2, 2026GAAP | $1.85 | – | – |
| Core adjusted EBITDA, nine months ended October 2, 2026non-GAAP | $441.5M | – | – |
| Core adjusted EBITDA margin, nine months ended October 2, 2026non-GAAP | 19.5% | – | – |
| Net cash provided by operating activities, three months ended October 2, 2026GAAP | $72.7M | – | – |
| Adjusted free cash flow, three months ended October 2, 2026non-GAAP | $60M | – | – |
| Net cash provided by operating activities, nine months ended October 2, 2026GAAP | $153M | – | – |
| Adjusted free cash flow, nine months ended October 2, 2026non-GAAP | $140.9M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Americas net sales, three months ended October 2, 2026Existing businesses (organic sales) increased $2.3 million, or 0.8%; acquisitions contributed $34.2 million, or 11.7%; and foreign currency translation contributed $8.1 million, or 2.8%. | $337.3M | – | 15.2% |
| EMEA & APAC net sales, three months ended October 2, 2026Existing businesses (organic sales) increased $11.6 million, or 2.7%; acquisitions contributed $43.2 million, or 9.9%; and foreign currency translation was $(2.7) million, or (0.6)%. | $487.2M | – | 12.0% |
| Americas core sales, three months ended October 2, 2026Core organic sales increased $2.3 million, or 0.8%. | $337.3M | – | 15.2% |
| EMEA & APAC core sales, three months ended October 2, 2026Core organic sales increased $13.6 million, or 3.4%. | $449.5M | – | 13.9% |
Full year 2026 outlook
- Revenue2026 Core net sales growth range 13.1% - 13.3%
- NoteOrganic growth 1.6% - 2.0%
- NoteAcquisitions ~9.5%
- NoteCurrency ~2.0%
- Note2026 Core adjusted EBITDA range $603 - $607
- Note2026 Core adjusted EPS range $5.28 - $5.33
Capital returns
- Payment of dividends of $19,690 for the nine months ended October 2, 2026.
- Payment of preferred dividends of $1,390 for the nine months ended October 2, 2026.
- No share repurchases were reported.
What drove it
- Third-quarter reported net sales growth comprised $13.9 million, or 1.9%, from existing businesses, $77.3 million, or 10.6%, from acquisitions, and $5.5 million, or 0.8%, from foreign currency translation.
- Third-quarter core sales growth comprised $15.9 million, or 2.3%, from core organic sales, $77.3 million, or 11.3%, from acquisitions, and $6.2 million, or 0.9%, from foreign currency translation.
- Core organic growth occurred in both segments.
- Management cited disciplined execution, investment in growth and the EBXai operating system as drivers of sales, margins and cash generation.
- Management cited new products, the acquisitions of EWM and Eddyfi, and cross-selling opportunities at ESAB and Eddyfi.
Concerns
- GAAP operating income was $91,932, compared with $106,618 in the prior-year quarter.
- Net income from continuing operations was $42,160, compared with $65,340 in the prior-year quarter.
- Interest expense and other, net was $36,511, compared with $23,584 in the prior-year quarter.
- Restructuring and other related charges were $11,329, compared with $4,347 in the prior-year quarter.
- The full-year 2026 core adjusted EBITDA range was reduced to $603 - $607 from $615 - $625, and the core adjusted EPS range was reduced to $5.28 - $5.33 from $5.40 - $5.50.
- Full-year organic growth guidance was reduced to 1.6% - 2.0% from 2.0% - 4.0%.
What to watch
- Delivery against full-year core net sales growth guidance of 13.1% - 13.3%, including organic growth guidance of 1.6% - 2.0%.
- Whether acquisitions, expected to contribute ~9.5% to 2026 core net sales growth, and currency, expected to contribute ~2.0%, continue to supply most of the projected growth.
- Execution against the reduced 2026 core adjusted EBITDA range of $603 - $607 and core adjusted EPS range of $5.28 - $5.33.
- Core adjusted EBITDA margin progression after third-quarter margin reached 19.8%.
- Cash generation following nine-month adjusted free cash flow of $140.9 million and acquisitions, net of cash received, of $(1,469,372).
Balance sheet and cash flow
- Cash and cash equivalents were $188,648 at October 2, 2026, compared with $185,863 at December 31, 2025.
- Current portion of debt was $9,357 and long-term debt was $2,319,712 at October 2, 2026.
- Total assets were $6,495,211 and total liabilities were $3,889,598 at October 2, 2026.
- Acquisitions, net of cash received, were $(1,469,372) for the nine months ended October 2, 2026.
- Purchases of property, plant and equipment were $(49,700) for the nine months ended October 2, 2026.
- Proceeds from borrowings on Senior Notes were $1,000,000 for the nine months ended October 2, 2026.
- Net cash provided by financing activities was $1,368,206 for the nine months ended October 2, 2026.
Analysis
ESAB delivered record third-quarter net sales of $824,521, up 13.3% from $727,845. The reported increase was led by acquisitions, which contributed $77.3 million, or 10.6%, while existing businesses contributed $13.9 million, or 1.9%, and foreign currency translation contributed $5.5 million, or 0.8%. Core organic sales growth was 2.3%, with positive core organic growth in both Americas and EMEA & APAC. Americas core organic sales increased 0.8%, while EMEA & APAC core organic sales increased 3.4%.
Margin performance improved on the company’s core non-GAAP measures. Gross profit margin was 39.3%, compared with 37.0%, and adjusted core gross profit margin was 40.2%, compared with 37.7%. Core adjusted EBITDA was $156.1 million, compared with $133.4 million, and core adjusted EBITDA margin expanded 40 basis points to 19.8%. Management attributed the results to disciplined execution, investment in growth and EBXai, while also highlighting new products and the EWM and Eddyfi acquisitions as extending its workflow offering and creating cross-selling opportunities.
GAAP profitability declined despite the sales and core EBITDA gains. Operating income was $91,932 versus $106,618, net income from continuing operations was $42,160 versus $65,340, and diluted earnings per share from continuing operations was $0.61 versus $1.04. Selling, general and administrative expense increased to $220,382 from $158,335, restructuring and other related charges rose to $11,329 from $4,347, and interest expense and other, net increased to $36,511 from $23,584. Acquisition-amortization and other related charges were $39.9 million in the quarter, compared with $16.5 million in the prior-year quarter.
Cash generation was lower than the prior-year period. Third-quarter net cash provided by operating activities was $72.7 million, compared with $81.5 million, and adjusted free cash flow was $60.0 million, compared with $86.4 million. For the nine months, acquisitions, net of cash received, were $(1,469,372), while long-term debt stood at $2,319,712 at October 2, 2026, compared with $1,232,540 at December 31, 2025. Cash and cash equivalents were $188,648 at October 2, 2026.
The updated full-year outlook reflects a narrower total core sales growth range of 13.1% - 13.3%, compared with 11.0% - 14.0% previously, but lower expected organic growth of 1.6% - 2.0% versus 2.0% - 4.0%. The company increased its expected M&A contribution to ~9.5% and currency contribution to ~2.0%. It reduced the core adjusted EBITDA range to $603 - $607 from $615 - $625 and reduced core adjusted EPS guidance to $5.28 - $5.33 from $5.40 - $5.50, making organic execution, acquisition contribution and margin delivery central to the remaining-year outlook.
Management, verbatim
ESAB delivered record third quarter core sales and adjusted EBITDA, with organic growth in both segments, despite a dynamic global environment and continued inflationary pressure. We improved sales, margins and cash generation sequentially. Disciplined execution, investment in growth and our EBXai operating system are delivering results.
Shyam P. Kambeyanda, ESAB President and CEO
With our new products, and the acquisitions of EWM and Eddyfi, we now serve our customers across the entire life of their most critical assets, from the first cut and weld through decades of inspection, monitoring and repair.
Shyam P. Kambeyanda, ESAB President and CEO
Not in the filing
stated, not guessed- Prior-quarter comparisons for reported key metrics were not provided.
- GAAP tax rate was not provided.
- Full-year 2026 revenue in dollars was not provided; the outlook provides a core net sales growth range.
- Forward gross margin, operating expenses and tax rate guidance were not provided.
- Share repurchases were not reported.
- The previous outlook covered the full year 2026 only, and this release reports the third quarter, so there is nothing to compare for this period.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
ESAB Corporation (NYSE: ESAB) released its third‑quarter 2026 earnings via an SEC Form 8‑K, providing both financial results and an updated outlook for the full year.
Ticker impact
ESAB issued its Q3 2026 results, reporting record sales and updated full-year guidance, including lowered EBITDA and EPS forecasts.
likely downside pressure as investors price in reduced EBITDA and EPS outlook
The company lowered its core adjusted EBITDA range to $603‑$607M from $615‑$625M and revised EPS guidance to $5.28‑$5.33 from $5.40‑$5.50, indicating weaker profitability.
Market effects
Industrial manufacturing sector may see modest pullback as a leading compounder trims outlook.
U.S. industrial stocks could face slight weakness in early trading.
Limited to companies with similar exposure to industrial compounder markets.
Counterpoint
If the market overreacts to the lowered guidance, a bounce could occur on the back of strong organic sales growth.
Key entities
- ExecutiveShyam P. Kambeyanda
President and CEO of ESAB, quoted on the results and outlook.



